Search Results - "Ramo, Cristina"
-
1
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial
Published in Lancet neurology (01-11-2021)“…Mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells, have been proposed as a promising therapeutic option for people with multiple sclerosis…”
Get full text
Journal Article -
2
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
Published in Lancet neurology (01-04-2017)“…Summary Background Alemtuzumab, an anti-CD52 antibody, is proven to be more efficacious than interferon beta-1a in the treatment of relapsing-remitting…”
Get full text
Journal Article -
3
Latitudinal-Related Variation in Wintering Population Trends of Greylag Geese (Anser Anser) along the Atlantic Flyway: A Response to Climate Change?
Published in PloS one (14-10-2015)“…The unusually high quality of census data for large waterbirds in Europe facilitates the study of how population change varies across a broad geographical…”
Get full text
Journal Article -
4
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients
Published in CNS neuroscience & therapeutics (01-12-2018)“…Summary Aims Fingolimod, an orally active immunomodulatory drug for relapsing‐remitting multiple sclerosis (RRMS), sequesters T cells in lymph nodes through…”
Get full text
Journal Article -
5
Optimal response to dimethyl fumarate is mediated by a reduction of Th1‐like Th17 cells after 3 months of treatment
Published in CNS neuroscience & therapeutics (01-09-2019)“…Aim Dimethyl fumarate (DMF) is one of the most promising therapies for relapsing‐remitting multiple sclerosis (RRMS) patients since it has shown…”
Get full text
Journal Article -
6
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study
Published in Journal of clinical medicine (23-11-2023)“…The EMCOVID project conducted a multi-centre cohort study to investigate the impact of COVID-19 on patients with Multiple Sclerosis (pwMS) receiving…”
Get full text
Journal Article -
7
trade‐off between overheating and camouflage on shorebird eggshell colouration
Published in Journal of avian biology (01-05-2016)“…In ground‐nesting birds egg colour and appearance may have evolved due to opposite selection pressures. Pigmentation and spottiness make the eggs darker and…”
Get full text
Journal Article -
8
Quail eggs in artificial nests change their coloration when exposed to ambient conditions: implication for studies on nest predation
Published in PeerJ (San Francisco, CA) (06-07-2021)“…Quail eggs have been widely used in field experiments, mainly to study factors associated with the risk of nest predation. Some shortcomings of using quail…”
Get full text
Journal Article -
9
Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients
Published in Cytometry. Part B, Clinical cytometry (01-03-2018)“…Background In natalizumab‐treated relapsing‐remitting MS (RRMS) patients, various extended interval dosing strategies are under evaluation to minimize severe…”
Get full text
Journal Article -
10
Physiological strategies of moult-migrating Black-necked Grebes (Podiceps nigricollis) in a polluted staging site according to blood chemistry
Published in Avian research (2023)“…After breeding, Black-necked Grebes (Podiceps nigricollis) perform a moult-migration to autumn hypersaline staging sites, where they moult the flight feathers…”
Get full text
Journal Article -
11
Latitudinal variation in biophysical characteristics of avian eggshells to cope with differential effects of solar radiation
Published in Ecology and evolution (01-08-2018)“…Solar radiation is an important driver of animal coloration, not only because of the effects of coloration on body temperature but also because coloration may…”
Get full text
Journal Article -
12
Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers
Published in Frontiers in immunology (03-07-2024)“…We present a case of multiple tumefactive demyelinating lesions (TDLs) emerging 24 months after the second cycle of alemtuzumab treatment. A woman with…”
Get full text
Journal Article -
13
Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers
Published in International journal of molecular sciences (01-04-2023)“…Since the early 1980s, Epstein-Barr virus (EBV) infection has been described as one of the main risk factors for developing multiple sclerosis (MS), and…”
Get full text
Journal Article -
14
Does the use of nest materials in a ground-nesting bird result from a compromise between the risk of egg overheating and camouflage?
Published in Biology open (09-12-2019)“…Many studies addressing the use of nest materials by animals have focused on only one factor to explain its function. However, the consideration of more than…”
Get full text
Journal Article -
15
Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4 + Cells Towards a Functional Hyporesponsiveness
Published in Frontiers in immunology (20-01-2021)“…The use of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases. Among the different…”
Get full text
Journal Article -
16
Single‐cell multi‐omics analysis of COVID‐19 patients with pre‐existing autoimmune diseases shows aberrant immune responses to infection
Published in European journal of immunology (01-01-2024)“…In COVID‐19, hyperinflammatory and dysregulated immune responses contribute to severity. Patients with pre‐existing autoimmune conditions can therefore be at…”
Get full text
Journal Article -
17
Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis
Published in Biomedicines (24-11-2021)“…Autologous antigen-specific therapies based on tolerogenic dendritic cells (tolDC) offer the possibility to treat autoimmune diseases by restoring homeostasis…”
Get full text
Journal Article -
18
MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients
Published in Frontiers in immunology (19-06-2019)“…The administration of autologous tolerogenic dendritic cells (tolDC) has become a promising alternative for the treatment of autoimmune diseases, such as…”
Get full text
Journal Article -
19
Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment
Published in Mediators of inflammation (2019)“…Peripheral blood biomarkers able to predict disease activity in multiple sclerosis (MS) patients have not been identified yet. Here, we analyzed the immune…”
Get full text
Journal Article -
20
Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies
Published in Journal of clinical medicine (29-04-2022)“…Background: Disease-modifying therapies (DMTs) used to treat multiple sclerosis (MS) alter the immune system and therefore increase the risk of infection…”
Get full text
Journal Article